Related Experiment Video

Updated: Jun 27, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs

Neil Ashley1, Joanna Poulton

  • 1University of Oxford, Nuffield Department of Obstetrics and Gynaecology, The Womens Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Biochemical and Biophysical Research Communications
|November 27, 2008
PubMed

Insights

Anthracyclines like doxorubicin intercalate into both nuclear and mitochondrial DNA, potentially explaining their toxicity. A new PicoGreen assay aids in studying these drug-DNA interactions and mitochondrial dysfunction.

Area of Science:

  • Molecular Biology
  • Pharmacology
  • Cell Biology

Background:

  • Anthracyclines are effective anti-cancer drugs but exhibit significant clinical toxicity.
  • Understanding the sub-cellular localization of these drugs is crucial for elucidating their mechanisms of action and toxicity.
  • Current methods for determining drug localization are limited.

Purpose of the Study:

  • To investigate the sub-cellular localization of anthracyclines using a novel fluorescent DNA dye.
  • To explore the interaction of anthracyclines with nuclear and mitochondrial DNA.
  • To develop a new assay for quantifying mitochondrial DNA (mtDNA) levels.

Main Methods:

  • Utilized the fluorescent DNA dye PicoGreen to study drug-DNA interactions within live cells.
  • Investigated the intercalation of anthracyclines and ethidium bromide into nuclear DNA and mtDNA.
  • Developed a novel flow-cytometry-based assay using PicoGreen quenching for mtDNA quantification.

Main Results:

  • Anthracyclines were found to intercalate into both nuclear DNA and mitochondrial DNA (mtDNA).
  • Ethidium bromide selectively intercalated into mtDNA, not nuclear DNA.
  • A new assay for quantifying mtDNA levels using PicoGreen quenching was successfully developed.

Conclusions:

  • Anthracycline intercalation into mtDNA may contribute to their observed mitochondrial toxicity.
  • The developed PicoGreen assay is a valuable tool for studying drug-DNA interactions in live cells.
  • This assay can facilitate therapeutic drug monitoring and kinetic studies in cancer patients.

More Related Videos

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates11:32

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...